tm
Seeing Is Believing
tm
Seeing Is Believing
INKT is currently covered by 4 analysts with an average price target of $6.14. This is a potential upside of $4.82 (365.15%) from yesterday's end of day stock price of $1.32.
Mink Therapeutics's activity chart (see below) currently has 4 price targets and 11 ratings on display. The stock rating distribution of INKT is 100% BUY.
Analysts average stock forecasts to be materialized ratio is 12.5% with an average time for these price targets to be met of 23 days.
Highest price target for INKT is $7, Lowest price target is $7, average price target is $6.14.
Most recent stock forecast was given by EMILY BODNAR from HC WAINWRIGHT on 12-May-2023. First documented stock forecast 09-Nov-2021.
Currently out of the existing stock ratings of INKT, 7 are a BUY (100%).
Analyst name
Rating
Current price target
Potential distance
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
7
$5.68 (430.30%)
7
11 months 3 days ago
0/4 (0%)
$5.28 (306.98%)
Buy
8
$6.68 (506.06%)
26
1 years 24 days ago
0/2 (0%)
$5.91 (282.78%)
Buy
3
$1.68 (127.27%)
30
1 years 24 days ago
1/2 (50%)
$0.91 (43.54%)
92
Buy
10
1 years 11 months 4 days ago
0/2 (0%)
$7.18 (254.61%)
What is INKT (Mink Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on INKT (Mink Therapeutics) with a proven track record?
Which analyst has the current lower performing score on INKT (Mink Therapeutics) with a proven track record?
Which analyst has the most public recommendations on INKT (Mink Therapeutics)?
Which analyst is the currently most bullish on INKT (Mink Therapeutics)?
Which analyst is the currently most reserved on INKT (Mink Therapeutics)?
